• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

持续的胆囊收缩素-B/胃泌素受体阻断并不损害慢性胃瘘大鼠的基础胃酸分泌或组胺刺激的胃酸分泌。

Sustained cholecystokinin-B/gastrin receptor blockade does not impair basal or histamine-stimulated acid secretion in chronic gastric fistula rats.

作者信息

Ding X Q, Kitano M, Håkanson R

机构信息

Department of Pharmacology, University of Lund, Sweden.

出版信息

Pharmacol Toxicol. 1998 Apr;82(4):177-82. doi: 10.1111/j.1600-0773.1998.tb01421.x.

DOI:10.1111/j.1600-0773.1998.tb01421.x
PMID:9584331
Abstract

Gastrin is a physiologically important secretagogue. It is thought to stimulate parietal cells indirectly by mobilizing histamine from enterochromaffin-like (ECL) cells in the oxyntic mucosa. Gastrin stimulates the secretory activity and growth of the ECL cells via an action on cholecystokinin-B/gastrin receptors. Acute cholecystokinin-B/gastrin receptor blockade is known to inhibit gastrin-stimulated acid secretion but whether sustained cholecystokinin-B/gastrin receptor blockade will impair basal, gastrin- and histamine-stimulated acid secretion remains uncertain. The present study was designed to study the effect of long-term (4 weeks) cholecystokinin-B/gastrin receptor blockade on basal and stimulated acid secretion in conscious rats. The selective cholecystokinin-B/gastrin receptor antagonist YM022 (3 mumol.kg-1.hr-1) was given to gastric fistula rats by continuous subcutaneous infusion via osmotic minipumps for various times from 2 hr to 4 weeks. Basal, gastrin- and histamine-stimulated acid secretion were examined during and after cessation of treatment. Basal and histamine-stimulated acid secretion was not affected by YM022 during the 4 week period of administration, whereas gastrin-induced acid secretion was inhibited. YM022 induced hypergastrinaemia in freely fed rats but did not affect the serum gastrin level in fasted rats. The serum gastrin concentration and gastrin-induced acid secretion returned to control levels 3-7 days after termination of YM022 administration.

摘要

胃泌素是一种具有重要生理意义的促分泌素。人们认为它通过动员胃底黏膜中肠嗜铬样(ECL)细胞释放组胺来间接刺激壁细胞。胃泌素通过作用于胆囊收缩素B/胃泌素受体来刺激ECL细胞的分泌活性和生长。已知急性阻断胆囊收缩素B/胃泌素受体可抑制胃泌素刺激的胃酸分泌,但持续阻断胆囊收缩素B/胃泌素受体是否会损害基础胃酸分泌、胃泌素和组胺刺激的胃酸分泌仍不确定。本研究旨在探讨长期(4周)阻断胆囊收缩素B/胃泌素受体对清醒大鼠基础胃酸分泌和刺激胃酸分泌的影响。通过渗透微型泵以3 μmol·kg⁻¹·hr⁻¹的剂量持续皮下输注选择性胆囊收缩素B/胃泌素受体拮抗剂YM022,给药时间从2小时至4周不等,对胃瘘大鼠进行给药。在治疗期间及停药后检测基础胃酸分泌、胃泌素和组胺刺激的胃酸分泌。在给药的4周期间,YM022对基础胃酸分泌和组胺刺激的胃酸分泌无影响,而胃泌素诱导的胃酸分泌受到抑制。YM022可使自由进食大鼠出现高胃泌素血症,但对禁食大鼠的血清胃泌素水平无影响。停药后3 - 7天,血清胃泌素浓度和胃泌素诱导的胃酸分泌恢复至对照水平。

相似文献

1
Sustained cholecystokinin-B/gastrin receptor blockade does not impair basal or histamine-stimulated acid secretion in chronic gastric fistula rats.持续的胆囊收缩素-B/胃泌素受体阻断并不损害慢性胃瘘大鼠的基础胃酸分泌或组胺刺激的胃酸分泌。
Pharmacol Toxicol. 1998 Apr;82(4):177-82. doi: 10.1111/j.1600-0773.1998.tb01421.x.
2
Effect of cholecystokinin-B/gastrin receptor blockade on gastric acid secretion in conscious rats.
Pharmacol Toxicol. 1996 Dec;79(6):324-30. doi: 10.1111/j.1600-0773.1996.tb00017.x.
3
Cholecystokinin-B/gastrin receptor blockade suppresses the activity of rat stomach ECL cells.胆囊收缩素B/胃泌素受体阻断可抑制大鼠胃肠嗜铬样细胞的活性。
Pharmacol Toxicol. 1997 Jul;81(1):19-25. doi: 10.1111/j.1600-0773.1997.tb00025.x.
4
Time-course of deactivation of rat stomach ECL cells following cholecystokinin B/gastrin receptor blockade.胆囊收缩素B/胃泌素受体阻断后大鼠胃肠嗜铬样细胞失活的时间进程。
Br J Pharmacol. 1997 Sep;122(1):1-6. doi: 10.1038/sj.bjp.0701316.
5
CCK2 receptor antagonists: pharmacological tools to study the gastrin-ECL cell-parietal cell axis.CCK2受体拮抗剂:研究胃泌素-肠嗜铬样细胞-壁细胞轴的药理学工具。
Regul Pept. 1999 Mar 17;80(1-2):1-12. doi: 10.1016/s0167-0115(99)00008-7.
6
YM022, a highly potent and selective CCKB antagonist inhibiting gastric acid secretion in the rat, the cat and isolated rabbit glands.YM022,一种高效且选择性的CCKB拮抗剂,可抑制大鼠、猫及离体兔腺体的胃酸分泌。
Fundam Clin Pharmacol. 1998;12(3):256-62. doi: 10.1111/j.1472-8206.1998.tb00952.x.
7
Reversibility of cholecystokinin-B/gastrin receptor blockade: a study of the gastrin-ECL cell axis in the rat.胆囊收缩素-B/胃泌素受体阻断的可逆性:大鼠胃泌素-肠嗜铬样细胞轴的研究
Pharmacol Toxicol. 1999 Apr;84(4):159-64. doi: 10.1111/j.1600-0773.1999.tb00893.x.
8
Long-lasting cholecystokinin(2) receptor blockade after a single subcutaneous injection of YF476 or YM022.单次皮下注射YF476或YM022后长效胆囊收缩素(2)受体阻断
Br J Pharmacol. 2000 Jun;130(3):699-705. doi: 10.1038/sj.bjp.0703342.
9
Comparative evaluation of the role of endogenous gastrin in basal acid secretion in conscious rats provided with chronic fistula and pylorus ligation.对患有慢性瘘管和幽门结扎的清醒大鼠内源性胃泌素在基础胃酸分泌中的作用进行比较评估。
Jpn J Pharmacol. 1996 Jul;71(3):223-30. doi: 10.1254/jjp.71.223.
10
YM022, a potent and selective gastrin/CCK-B receptor antagonist, inhibits peptone meal-induced gastric acid secretion in Heidenhain pouch dogs.YM022是一种强效且选择性的胃泌素/胆囊收缩素B受体拮抗剂,可抑制海登海因小胃犬中蛋白胨餐诱导的胃酸分泌。
Dig Dis Sci. 1997 Apr;42(4):707-14. doi: 10.1023/a:1018887308280.

引用本文的文献

1
Pharmacological analysis of CCK2 receptor antagonists using isolated rat stomach ECL cells.使用分离的大鼠胃肠嗜铬样细胞对CCK2受体拮抗剂进行药理学分析。
Br J Pharmacol. 1999 May;127(2):530-6. doi: 10.1038/sj.bjp.0702538.